This topic contains a solution. Click here to go to the answer

Author Question: A patient with Parkinson's disease is taking levodopa/carbidopa (Sinemet) and reports occasional ... (Read 146 times)

stock

  • Hero Member
  • *****
  • Posts: 573
A patient with Parkinson's disease is taking levodopa/carbidopa (Sinemet) and reports occasional periods of loss of drug effect lasting from minutes to several hours.
 
  The nurse questions the patient further and discovers that these episodes occur at different times related to the medication administration. The nurse will contact the provider to discuss:
  a. administering a catechol-O-methyltransferase (COMT) inhibitor, such as entacapone.
  b. adding the DA-releasing agent amantadine to the regimen.
  c. giving a direct-acting dopamine agonist.
  d. shortening the dosing interval of levodopa/carbidopa.

Question 2

A group of nursing students asks a nurse to explain the blood-brain barrier. The nurse would be correct to say that the blood-brain barrier:
 
  a. prevents some potentially toxic substances from crossing into the central nervous system.
  b. causes infants to be less sensitive to CNS drugs and thus require larger doses.
  c. allows only ionized or protein-bound drugs to cross into the central nervous system.
  d. prevents lipid-soluble drugs from entering the central nervous system.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

raenoj

  • Sr. Member
  • ****
  • Posts: 340
Answer to Question 1

ANS: A
This patient is describing abrupt loss of effect, or the off phenomenon, which is treated with entacapone or another COMT inhibitor. Amantadine is used to treat dyskinesias. A direct-acting dopamine agonist is useful for gradual loss of effect, which occurs at the end of the dosing interval as the dose is wearing off. Shortening the dosing interval does not help with abrupt loss of effect.

Answer to Question 2

ANS: A
The blood-brain barrier can prevent some drugs and some toxic substances from entering the CNS. The blood-brain barrier in infants is not fully developed, so infants are more sensitive to CNS drugs and often require lower doses. The blood-brain barrier prevents highly ionized and protein-bound drugs from crossing into the CNS and allows lipid-soluble drugs and those that can cross via specific transport systems to enter.




stock

  • Member
  • Posts: 573
Reply 2 on: Jul 23, 2018
Thanks for the timely response, appreciate it


amynguyen1221

  • Member
  • Posts: 355
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Vaccines cause herd immunity. If the majority of people in a community have been vaccinated against a disease, an unvaccinated person is less likely to get the disease since others are less likely to become sick from it and spread the disease.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Many supplement containers do not even contain what their labels say. There are many documented reports of products containing much less, or more, that what is listed on their labels. They may also contain undisclosed prescription drugs and even contaminants.

For a complete list of videos, visit our video library